BBIO logo

BridgeBio Pharma (BBIO) Total expenses

Annual total expenses:

$799.27M+$190.52M(+31.30%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BBIO annual total expenses is $799.27 million, with the most recent change of +$190.52 million (+31.30%) on December 31, 2024.
  • During the last 3 years, BBIO annual total expenses has risen by +$152.92 million (+23.66%).
  • BBIO annual total expenses is now at all-time high.

Performance

BBIO Total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOincome statement metrics

Quarterly total expenses:

$220.44M-$6.78M(-2.98%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BBIO quarterly total expenses is $220.44 million, with the most recent change of -$6.78 million (-2.98%) on March 31, 2025.
  • Over the past year, BBIO quarterly total expenses has increased by +$13.06 million (+6.30%).
  • BBIO quarterly total expenses is now -2.98% below its all-time high of $227.22 million, reached on December 31, 2024.

Performance

BBIO Quarterly total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOincome statement metrics

Total expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

BBIO Total expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+31.3%+6.3%
3 y3 years+23.7%+44.4%
5 y5 years+160.5%+115.1%

BBIO Total expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+46.4%-3.0%+78.6%
5 y5-yearat high+160.5%-3.0%+115.1%
alltimeall timeat high+1722.4%-3.0%+533.7%

BBIO Total expenses History

DateAnnualQuarterly
Mar 2025
-
$220.44M(-3.0%)
Dec 2024
$799.27M(+31.3%)
$227.22M(+19.7%)
Sep 2024
-
$189.86M(+8.6%)
Jun 2024
-
$174.82M(-15.7%)
Mar 2024
-
$207.38M(+16.2%)
Dec 2023
$608.75M(+11.5%)
$178.41M(+10.5%)
Sep 2023
-
$161.51M(+12.0%)
Jun 2023
-
$144.21M(+15.7%)
Mar 2023
-
$124.62M(+1.0%)
Dec 2022
$546.09M(-15.5%)
$123.41M(-0.8%)
Sep 2022
-
$124.44M(-14.5%)
Jun 2022
-
$145.53M(-4.7%)
Mar 2022
-
$152.71M(-14.4%)
Dec 2021
$646.35M
$178.50M(+17.6%)
Sep 2021
-
$151.84M(+2.6%)
DateAnnualQuarterly
Jun 2021
-
$148.04M(-11.9%)
Mar 2021
-
$167.97M(+31.6%)
Dec 2020
$482.73M(+57.3%)
$127.61M(-0.4%)
Sep 2020
-
$128.07M(+2.8%)
Jun 2020
-
$124.57M(+21.5%)
Mar 2020
-
$102.49M(+10.8%)
Dec 2019
$306.80M(+67.0%)
$92.46M(+13.8%)
Sep 2019
-
$81.27M(+17.2%)
Jun 2019
-
$69.32M(+8.7%)
Mar 2019
-
$63.75M(-2.8%)
Dec 2018
$183.66M(+318.8%)
$65.58M(+58.2%)
Sep 2018
-
$41.46M(+19.2%)
Jun 2018
-
$34.78M(-16.9%)
Mar 2018
-
$41.84M
Dec 2017
$43.86M
-

FAQ

  • What is BridgeBio Pharma annual total expenses?
  • What is the all time high annual total expenses for BridgeBio Pharma?
  • What is BridgeBio Pharma annual total expenses year-on-year change?
  • What is BridgeBio Pharma quarterly total expenses?
  • What is the all time high quarterly total expenses for BridgeBio Pharma?
  • What is BridgeBio Pharma quarterly total expenses year-on-year change?

What is BridgeBio Pharma annual total expenses?

The current annual total expenses of BBIO is $799.27M

What is the all time high annual total expenses for BridgeBio Pharma?

BridgeBio Pharma all-time high annual total expenses is $799.27M

What is BridgeBio Pharma annual total expenses year-on-year change?

Over the past year, BBIO annual total expenses has changed by +$190.52M (+31.30%)

What is BridgeBio Pharma quarterly total expenses?

The current quarterly total expenses of BBIO is $220.44M

What is the all time high quarterly total expenses for BridgeBio Pharma?

BridgeBio Pharma all-time high quarterly total expenses is $227.22M

What is BridgeBio Pharma quarterly total expenses year-on-year change?

Over the past year, BBIO quarterly total expenses has changed by +$13.06M (+6.30%)
On this page